Delivery Order SPE2DB25D7068-SPE2DB25FTVVW

Award Date 3/14/25
Potential Completion Date 3/17/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $2,292.26 firm fixed-price delivery order is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S" medical products. The contract has an ultimate completion date of December 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 70S", a pharmaceutical product, with a ceiling value of $1,867.19 and a completion date of May 2, 2024. The contract is a firm-fixed price type and does not have a set-aside designation, indicating open competition....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 50S" to the Defense Logistics Agency (DLA). The $2,558.92 firm fixed-price delivery order contract has a completion date of December 11, 2024. The contract was not set aside for any specific business category. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,256.27 and is a delivery order for "REFRESH PLUS 0.5% EYE DROPS 30S". The contract is a firm fixed price, with an ultimate completion date of January 29, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,776.00, is for the delivery of "REFRESH PLUS 0.5% EYE DROPS 30S" medical supplies. The contract has a firm fixed-price pricing type and an ultimate completion date of January 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,893.96 delivery order contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS 30S" medical products. The contract is a firm fixed-price, with an ultimate completion date of January 14, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,255.01 Firm Fixed Price Delivery Order is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 50S" and has an ultimate completion date of May 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,354.06 firm fixed-price delivery order is for "REFRESH PLUS 0.5% EYE DROPS UD 50S" and has a completion date of March 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "REFRESH PLUS 0.5% EYE DROPS UD 70S", with a ceiling value of $1,145.94 and a period of performance through January 9, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,752.09 and is for the delivery of "REFRESH PLUS 0.5% EYE DROPS 30S" medical supplies. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract...
  • SPE2DB25D7068
    Indefinite Delivery Contract
  • SPE2DB25D7068-SPE2DB25FTVVW
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,429.75 and covers the provision of "REFRESH PLUS 0.5% EYE DROPS 30S" medical products. The contract is a firm fixed-price delivery order with an ultimate completion date of March 17, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 6/13/25, 9:42 AM